Correspondence 0001104659-23-119136 from PaxMedica, Inc. (PXMD) (CIK 0001811623)

PaxMedica, Inc. (PXMD) (CIK 0001811623)
Date: Nov. 16, 2023 · CIK: 0001811623 · Accession: 0001104659-23-119136

View on Edgar

AI Filing Summary & Sentiment

File numbers found in text: 333-275416

Date

November 16, 2023

Author

/s/

Form

CORRESP

Company

PaxMedica, Inc. (PXMD) (CIK 0001811623)

Letter

VIA EDGAR Office of Life Sciences Division of Corporation Finance United States Securities and Exchange Commission Attention: Doris Stacey Gama Re: PaxMedica, Inc. Acceleration Request for Registration Statement on Form S-1 File No. 333-275416

Dear Ms. Gama,

Pursuant to Rule 461 under the Securities Act of 1933, as amended (the “Act”), PaxMedica, Inc. (the “Company”) hereby requests that the effective date of the above-referenced registration statement, as amended (the “Registration Statement”), be accelerated to November 20, 2023, at 9:00 a.m., Eastern Time, or as soon thereafter as practicable, unless we or our outside counsel, Dechert LLP, request by telephone that such Registration Statement be declared effective at some other time. In making this acceleration request, the Company acknowledges that it is aware of its responsibilities under the Act.

Once the Registration Statement is effective, please orally confirm the event with our counsel, Dechert LLP, by calling Anna Tomczyk at (212) 641-5626 or Austin Day at (704) 339-3159.

If you have any questions regarding this request, please contact Anna Tomczyk of Dechert LLP at (212) 641-5626.

Sincerely,
PAXMEDICA, INC.

Show Raw Text

CORRESP
1
filename1.htm

November 16, 2023

VIA EDGAR

Office of Life Sciences

Division of Corporation Finance

United States Securities and Exchange Commission

100 F Street, N.E.

Washington, D.C. 20549

    Attention:
    Doris Stacey Gama

    Re:
    PaxMedica, Inc.

Acceleration Request for Registration Statement on Form S-1

File No. 333-275416

Dear Ms. Gama,

Pursuant to Rule 461
under the Securities Act of 1933, as amended (the “Act”), PaxMedica, Inc. (the “Company”) hereby
requests that the effective date of the above-referenced registration statement, as amended (the “Registration Statement”),
be accelerated to November 20, 2023, at 9:00 a.m., Eastern Time, or as soon thereafter as practicable, unless we or our outside counsel,
Dechert LLP, request by telephone that such Registration Statement be declared effective at some other time. In making this acceleration
request, the Company acknowledges that it is aware of its responsibilities under the Act.

Once the Registration Statement
is effective, please orally confirm the event with our counsel, Dechert LLP, by calling Anna Tomczyk at (212) 641-5626 or Austin Day at
(704) 339-3159.

If you have any questions
regarding this request, please contact Anna Tomczyk of Dechert LLP at (212) 641-5626.

    Sincerely,

    PAXMEDICA, INC.

    /s/
    Howard Weisman

    Howard Weisman Chief Executive Officer

    cc:
    Anna Tomczyk, Dechert LLP

SecProbe.io